Hsin-Che Lin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Peritoneal Dialysis

Hepatitis B Virus

Prognostic Factors

Patient Reported Outcomes

Top Venues

Alimentary pharmacology & therapeutics

Clinical and translational gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Hsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply. Alimentary pharmacology & therapeutics 59 (12) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply. Alimentary pharmacology & therapeutics 59 (12) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Jessica Liu, Mei-Hung Pan, Mei-Hsuan Lee, Richard Batrla-Utermann, Sheng-Nan Lu, Chuen-Fei Chen, Hwai-I Yang, Chien-Jen Chen
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (8) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Jessica Liu, Mei-Hung Pan, Mei-Hsuan Lee, Richard Batrla-Utermann, Sheng-Nan Lu, Chuen-Fei Chen, Hwai-I Yang, Chien-Jen Chen
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (8) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Jessica Liu, Mei-Hung Pan, Mei-Hsuan Lee, Richard Batrla-Utermann, Sheng-Nan Lu, Chuen-Fei Chen, Hwai-I Yang, Chien-Jen Chen
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary pharmacology & therapeutics (2024)
Hsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' reply. Alimentary pharmacology & therapeutics 59 (11) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' reply. Alimentary pharmacology & therapeutics 59 (11) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Jessica Liu, Mei-Hung Pan, Mei-Hsuan Lee, Richard Batrla-Utermann, Sheng-Nan Lu, Chuen-Fei Chen, Hwai-I Yang, Chien-Jen Chen
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (8) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' reply. Alimentary pharmacology & therapeutics (2024)
Hsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply. Alimentary pharmacology & therapeutics (2024)
Hsin-Che Lin, Wen-Juei Jeng, Jessica Liu, Mei-Hung Pan, Mei-Hsuan Lee, Richard Batrla-Utermann, Sheng-Nan Lu, Chuen-Fei Chen, Hwai-I Yang, Chien-Jen Chen
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (8) (2024)
Hsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Editorial: High qHBsAg-Is it a good or bad signal? Authors' reply. Alimentary pharmacology & therapeutics 59 (12) (2024)
Hsin-Che Lin, Jessica Liu, Mei-Hung Pan, Mei-Hsuan Lee, Richard Batrla-Utermann, Sheng-Nan Lu, Wen-Juei Jeng, Hwai-I Yang, Chien-Jen Chen
Rapid decline rather than absolute level of HBsAg predicts its seroclearance in untreated chronic hepatitis B patients from Taiwanese communities. Clinical and translational gastroenterology (2023)